Тёмный

Overcoming Challenges in AAV and LV Viral Vector Manufacturing 

IDT Biologika
Подписаться 46
Просмотров 421
50% 1

Overcoming Challenges in AAV and LV Viral Vector Manufacturing: A Platform Based Approach for Optimizing Timeline, Cost and Effort Into Clinics
Watch our expert talking about our AAV and LV expertise and how we can help your team to design a seamless and scalable vector-production process.
Learn more about
- How to leverage innovative testing and manufacturing platforms to reduce timelines while increasing cost-savings for viral vector production
- About the benefits of partnering with experienced CDMOs with AAV and LVV manufacturing experience
- And more
#IDTBiologika #cellandgene #viralvectors #AAV #LV
Connect with us to stay up to date with the latest news from IDT Biologika:
➜ Facebook: / idtbiologika
➜ Twitter: / idtbiologika
➜ LinkedIn: / idtbiologika
➜ Instagram: idtbiologik...

Наука

Опубликовано:

 

26 сен 2023

Поделиться:

Ссылка:

Скачать:

Готовим ссылку...

Добавить в:

Мой плейлист
Посмотреть позже
Комментарии    
Далее
100 Jahre IDT Biologika - der Jubiläumsfilm
10:41
Просмотров 1,1 тыс.
How To Price For B2B | Startup School
17:46
Просмотров 27 тыс.
ОБСЛУЖИЛИ САМЫЙ ГРЯЗНЫЙ ПК
1:00